Publication | Closed Access

An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial

ThrombosisVenous DiseaseVenous ThrombosisOpen-label RandomizedHematologyPediatricsProtekt TrialMedicineAnticoagulantHeparins